165 related articles for article (PubMed ID: 27136467)
1. White blood cell counts and neutrophil to lymphocyte ratio in the diagnosis of testicular cancer: a simple secondary serum tumor marker.
Yuksel OH; Verit A; Sahin A; Urkmez A; Uruc F
Int Braz J Urol; 2016; 42(1):53-9. PubMed ID: 27136467
[TBL] [Abstract][Full Text] [Related]
2. The relationship of neutrophil to lymphocyte ratio with testicular cancer.
Ilktac A; Dogan B; Ersoz C; Akcay M; Akbulut H
Int Braz J Urol; 2020; 46(1):101-107. PubMed ID: 31851466
[TBL] [Abstract][Full Text] [Related]
3. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-to-lymphocyte ratio as a predictor of preoperative tumor staging in testicular germ cell tumors.
Jankovich M; Jankovichova T; Ondrus D; Breza J
Bratisl Lek Listy; 2017; 118(9):510-512. PubMed ID: 29061055
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte and platelet counts as prognostic values of testicular germ cell tumours.
Herraiz-Raya L; Moreillo-Vicente L; Martínez-Ruiz J; Agustí-Martínez A; Fernández-Anguita PJ; Esper-Rueda JA; Salce-Marte L; Armas-Álvarez A; Díaz de Mera-Sánchez Migallón I; Martínez-Alfaro C; Giménez-Bachs JM; Donate-Moreno MJ; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2019; 43(6):284-292. PubMed ID: 31085041
[TBL] [Abstract][Full Text] [Related]
6. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
[TBL] [Abstract][Full Text] [Related]
7. Increased neutrophil/lymphocyte ratio in testicular cancer.
Şahin A; Toprak T; Kutluhan MA; Vural Y; Ürkmez A; Verit A
Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266274
[TBL] [Abstract][Full Text] [Related]
8. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
van Agthoven T; Eijkenboom WMH; Looijenga LHJ
Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
[TBL] [Abstract][Full Text] [Related]
9. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
Badia RR; Abe D; Wong D; Singla N; Savelyeva A; Chertack N; Woldu SL; Lotan Y; Mauck R; Ouyang D; Meng X; Lewis CM; Majmudar K; Jia L; Kapur P; Xu L; Frazier AL; Margulis V; Strand DW; Coleman N; Murray MJ; Amatruda JF; Lafin JT; Bagrodia A
J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
[TBL] [Abstract][Full Text] [Related]
10. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
[TBL] [Abstract][Full Text] [Related]
11. Testicular cancer. Clinical practice guidelines in oncology.
Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
[No Abstract] [Full Text] [Related]
12. Serum tumor markers in the evaluation of male germ cell tumors.
Barlow LJ; Badalato GM; McKiernan JM
Nat Rev Urol; 2010 Nov; 7(11):610-7. PubMed ID: 21068762
[TBL] [Abstract][Full Text] [Related]
13. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
[TBL] [Abstract][Full Text] [Related]
14. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic impact of preoperative complete blood count based systemic inflammatory markers in testicular cancer.
Arda E; Arikan G; Akdere H; Akgul M; Yuksel I
Int Braz J Urol; 2020; 46(2):216-223. PubMed ID: 32022510
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of Trace Elements in Patients with Testicular Cancers.
Kaba M; Pirinççi N; Yüksel MB; Gecit İ; Güneş M; Demir M; Akkoyun H; Demir H
Int Braz J Urol; 2015; 41(6):1101-7. PubMed ID: 26742967
[TBL] [Abstract][Full Text] [Related]
17. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
[TBL] [Abstract][Full Text] [Related]
18. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
19. RE: White blood cell counts and neutrophil to lymphocyte ratio in the diagnosis of testicular cancer: a simple secondary serum tumor marker.
Demirer Z; Güragac A; Uguz S; Uslu AU; Zor M
Int Braz J Urol; 2016; 42(6):1251-1252. PubMed ID: 27813388
[No Abstract] [Full Text] [Related]
20. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
